Sequel twiist(TM) Automated Insulin Delivery (AID) system
Sequel’s twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance
March 18, 2024 07:05 ET | Sequel Med Tech
Sequel’s twiist™ automated insulin delivery system receives FDA 510(k) clearance. Significant advancements for people with people with Type 1 diabetes.
Erkim logo.jpg
Er-Kim Announces Exclusive Distribution Agreement with Ascendis Pharma A/S to Commercialize 3 Endocrinology Disease Treatments Across Central & Eastern Europe and Turkey
January 08, 2024 18:01 ET | Er-Kim
Er-Kim is appointed as the exclusive Ascendis A/S endocrinology distributor across Central & Eastern Europe and Turkey
Transparency Market Research
Immunoassay Market Set to Surge at 5.0% CAGR, to Reach USD 48.7 billion by 2031 | Transparency Market Research, Inc.
January 04, 2024 10:30 ET | Transparency Market Research
Wilmington, Delaware, United States, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The immunoassay market was valued at US$ 31.5 billion in 2022. A CAGR of 5.0% is expected...
Diabetes and Me - cover
Living with diabetes for decades
December 05, 2023 08:00 ET | Norton Healthcare
LOUISVILLE, Ky., Dec. 05, 2023 (GLOBE NEWSWIRE) -- In her new book, “Diabetes and Me: Living a Healthy and Empowered Life in the Face of Diabetes” (ISBN-13 9781633310803, Nov. 14, 2023),...
TIP_link_300x300.jpg
Home Infusion Therapy Market Size to Hit 8.6% CAGR with Infusion Pumps Segment Driving Growth During 2022–2028 | The Insight Partners
October 24, 2023 14:46 ET | The Insight Partners
Pune, India, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biologicals to an individual at home. The components needed...
The Alpine Center CCPHP
Dr. Christopher Fox and N.P. Sarah Sato Collaborate with Castle Connolly Private Health Partners to Create The Alpine Center CCPHP Concierge Medicine Program
October 16, 2023 11:00 ET | Castle Connolly Private Health Partners
Dr. Christopher Fox and N.P. Sarah Sato Collaborate with Castle Connolly Private Health Partners to Create The Alpine Center CCPHP Concierge Program
Marius_logo_CMYK_no background.png
Marius Pharmaceuticals Expands Access of KYZATREX™ (testosterone undecanoate) to Department of Veterans Affairs (VA), Pledging Support for Proper Hormonal Balance Among Military Personnel
September 19, 2023 09:30 ET | Marius Pharmaceuticals LLC
RALEIGH, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, is proud to announce the...
Transparency Market Research
Pharmaceutical Intermediates Market Predicted to Reach USD 53.4 billion by 2031, Expanding at a CAGR of 6% Says, Transparency Market Research
August 29, 2023 04:53 ET | Transparency Market Research
Wilmington, Delaware, United States, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global pharmaceutical intermediates market is projected to flourish at a CAGR of 6%...
Marius_logo_CMYK_no background.png
Marius Pharmaceuticals Supports AXYS 2023 Virtual Family Conference, Spotlighting KYZATREX™ for XY Chromosome Variations, such as Klinefelter’s Syndrome
June 20, 2023 08:30 ET | Marius Pharmaceuticals LLC
RALEIGH, N.C., June 20, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company specializing in therapies for hypogonadism or testosterone deficiency, announced today...
Marius_logo_CMYK_no background.png
Marius Pharmaceuticals Announces Two Key Patents Related to KYZATREX™ in FDA Orange Book
June 09, 2023 10:00 ET | Marius Pharmaceuticals LLC
RALEIGH, N.C., June 09, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company focused on therapies designed for hypogonadism or testosterone deficiency, announced...